# The BANGALORE Study; Combination of Berberine, Lipoic Acid, and Picrorhiza

> **NCT01696448** · NA · COMPLETED · sponsor: **Carmel Biosciences** · enrollment: 28 (actual)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** CAR-191
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01696448
- **Lead sponsor:** Carmel Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2014-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01696448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01696448, "The BANGALORE Study; Combination of Berberine, Lipoic Acid, and Picrorhiza". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01696448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*